Fortune: Pfizer’s Best-Selling Drug Is Actually a Vaccine—and Its Price Keeps Increasing
Fortune: Pfizer’s Best-Selling Drug Is Actually a Vaccine—and Its Price Keeps Increasing by Erin Elizabeth for Health Nut News
TDC Note – If you missed “There’s No Money In Curing People” you really need to watch it. It explains the medical industrial complex in less than 20 minutes. It’s a good possibility it will create a desire within you to seek alternative medicine and a healthier lifestyle – these people actually hate you and want you just well enough to afford the next prescription.
You might know Pfizer for their drug Viagra. But did you know that their best-selling drug isn’t a drug at all but a vaccine?
According to the media company Axios, Pfizer’s pneumococcal vaccine Prevnar 13 (which is supposed to prevent infection caused by pneumococcal bacteria, think ear and sinus stuff as well as pneumonia and meningitis) is their biggest moneymaker. Why? Well, in 2014, the CDC recommended that more than just kids under the age of 2 and adults with “certain chronic conditions” get the vaccine; thanks to sufficient fear mongering and the insistence that adults ages 65 and older get the jab, profits on Prevnar skyrocketed to a staggering $23.4 billion.
If you’ve ever wondered why on earth vaccine companies fight so hard to prevent us from suing them when their vaccines cause serious harm or death, just read the sentence in the paragraph above one more time. (Hint: It’s the one that’s in bold.)
Despite of—or maybe because of that extra demand—Pfizer also continued to raise the price of Prevnar 13, which went up steadily for years despite it being a fairly widely administered vaccination, according to Kasier Health News. Despite the formula remaining relatively unchanged, between 2010 and 2017, the price went up between 5-8% annually, which resulted in a more than 50% increase over that eight-year period.